Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration

P. D. Yorgin, D. K. Eklund, Amira Al-Uzri, L. Whitesell, A. A. Theodorou

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Continuous venovenous hemofiltration/hemodiafiltration (CVVH/D) is commonly used to provide renal replacement therapy for critically ill patients who are hemodynamically unstable. Occasionally, the addition of plasmapheresis therapy is necessary for some conditions, including immune-mediated acute renal failure, sepsis, fulminant hepatic failure, and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Most tertiary care facilities provide centrifugation plasmapheresis instead of membrane plasmapheresis, because of the requirement for both therapeutic plasma exchange and pheresis of cellular blood products. We report a new technique where centrifugation plasmapheresis and CVVHD (P-CVVHD) are combined and used concurrently. Blood from the patient was concurrently filtered utilizing a Hospal BSM 22 machine with a Multiflow 60 hemofilter and a Cobe Spectra continuous cell separator in a parallel configuration. P-CVVHD is technically possible and can be used for long periods of time with limited risks. There may be advantages to P-CVVHD compared with discontinuous combined CVVH/D and plasmapheresis therapy.

Original languageEnglish (US)
Pages (from-to)18-21
Number of pages4
JournalPediatric Nephrology
Volume14
Issue number1
StatePublished - Jan 2000
Externally publishedYes

Fingerprint

Hemodiafiltration
Plasmapheresis
Centrifugation
Hemofiltration
Thrombotic Thrombocytopenic Purpura
Hemolytic-Uremic Syndrome
Blood Component Removal
Plasma Exchange
Renal Replacement Therapy
Acute Liver Failure
Tertiary Healthcare
Acute Kidney Injury
Critical Illness
Sepsis
Therapeutics
Membranes

Keywords

  • Acute renal failure
  • Hemofiltration
  • Hemolytic anemia
  • Sepsis

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Yorgin, P. D., Eklund, D. K., Al-Uzri, A., Whitesell, L., & Theodorou, A. A. (2000). Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration. Pediatric Nephrology, 14(1), 18-21.

Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration. / Yorgin, P. D.; Eklund, D. K.; Al-Uzri, Amira; Whitesell, L.; Theodorou, A. A.

In: Pediatric Nephrology, Vol. 14, No. 1, 01.2000, p. 18-21.

Research output: Contribution to journalArticle

Yorgin, PD, Eklund, DK, Al-Uzri, A, Whitesell, L & Theodorou, AA 2000, 'Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration', Pediatric Nephrology, vol. 14, no. 1, pp. 18-21.
Yorgin, P. D. ; Eklund, D. K. ; Al-Uzri, Amira ; Whitesell, L. ; Theodorou, A. A. / Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration. In: Pediatric Nephrology. 2000 ; Vol. 14, No. 1. pp. 18-21.
@article{a423310c52994d64acd068c0618f0206,
title = "Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration",
abstract = "Continuous venovenous hemofiltration/hemodiafiltration (CVVH/D) is commonly used to provide renal replacement therapy for critically ill patients who are hemodynamically unstable. Occasionally, the addition of plasmapheresis therapy is necessary for some conditions, including immune-mediated acute renal failure, sepsis, fulminant hepatic failure, and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Most tertiary care facilities provide centrifugation plasmapheresis instead of membrane plasmapheresis, because of the requirement for both therapeutic plasma exchange and pheresis of cellular blood products. We report a new technique where centrifugation plasmapheresis and CVVHD (P-CVVHD) are combined and used concurrently. Blood from the patient was concurrently filtered utilizing a Hospal BSM 22 machine with a Multiflow 60 hemofilter and a Cobe Spectra continuous cell separator in a parallel configuration. P-CVVHD is technically possible and can be used for long periods of time with limited risks. There may be advantages to P-CVVHD compared with discontinuous combined CVVH/D and plasmapheresis therapy.",
keywords = "Acute renal failure, Hemofiltration, Hemolytic anemia, Sepsis",
author = "Yorgin, {P. D.} and Eklund, {D. K.} and Amira Al-Uzri and L. Whitesell and Theodorou, {A. A.}",
year = "2000",
month = "1",
language = "English (US)",
volume = "14",
pages = "18--21",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration

AU - Yorgin, P. D.

AU - Eklund, D. K.

AU - Al-Uzri, Amira

AU - Whitesell, L.

AU - Theodorou, A. A.

PY - 2000/1

Y1 - 2000/1

N2 - Continuous venovenous hemofiltration/hemodiafiltration (CVVH/D) is commonly used to provide renal replacement therapy for critically ill patients who are hemodynamically unstable. Occasionally, the addition of plasmapheresis therapy is necessary for some conditions, including immune-mediated acute renal failure, sepsis, fulminant hepatic failure, and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Most tertiary care facilities provide centrifugation plasmapheresis instead of membrane plasmapheresis, because of the requirement for both therapeutic plasma exchange and pheresis of cellular blood products. We report a new technique where centrifugation plasmapheresis and CVVHD (P-CVVHD) are combined and used concurrently. Blood from the patient was concurrently filtered utilizing a Hospal BSM 22 machine with a Multiflow 60 hemofilter and a Cobe Spectra continuous cell separator in a parallel configuration. P-CVVHD is technically possible and can be used for long periods of time with limited risks. There may be advantages to P-CVVHD compared with discontinuous combined CVVH/D and plasmapheresis therapy.

AB - Continuous venovenous hemofiltration/hemodiafiltration (CVVH/D) is commonly used to provide renal replacement therapy for critically ill patients who are hemodynamically unstable. Occasionally, the addition of plasmapheresis therapy is necessary for some conditions, including immune-mediated acute renal failure, sepsis, fulminant hepatic failure, and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Most tertiary care facilities provide centrifugation plasmapheresis instead of membrane plasmapheresis, because of the requirement for both therapeutic plasma exchange and pheresis of cellular blood products. We report a new technique where centrifugation plasmapheresis and CVVHD (P-CVVHD) are combined and used concurrently. Blood from the patient was concurrently filtered utilizing a Hospal BSM 22 machine with a Multiflow 60 hemofilter and a Cobe Spectra continuous cell separator in a parallel configuration. P-CVVHD is technically possible and can be used for long periods of time with limited risks. There may be advantages to P-CVVHD compared with discontinuous combined CVVH/D and plasmapheresis therapy.

KW - Acute renal failure

KW - Hemofiltration

KW - Hemolytic anemia

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=0033974457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033974457&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 18

EP - 21

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 1

ER -